About Lanluma®
Lanluma® is a premium brand specializing in collagen stimulators, known for its innovative approach to skin rejuvenation and volume enhancement. Lanluma® products are designed to stimulate the body's natural collagen production, providing gradual and long-lasting improvements in skin texture and firmness. Ideal for treating areas such as the face, neck, and body, Lanluma® helps to restore youthful volume and smooth out fine lines and wrinkles. With a focus on safety and efficacy, Lanluma® collagen stimulators offer a non-surgical solution for those seeking natural-looking enhancements. Experience the revitalizing effects of Lanluma® and achieve a more youthful, radiant appearance.
Lanluma® V
Lanluma® V is a cutting-edge poly-L-lactic acid (PLLA) biostimulatory filler developed by Sinclair Pharma, a global leader in aesthetic dermatology. Specially formulated for body contouring and volume enhancement, Lanluma® V stimulates natural collagen production to improve shape, skin quality, and texture over time. Designed for safe and effective subcutaneous application, it offers a non-surgical solution for patients seeking natural yet noticeable results in areas such as the buttocks, hips, thighs, and arms.
Lanluma® V contains pharmaceutical-grade PLLA microparticles suspended in a sterile, reconstitutable powder form. Once injected, it initiates collagen neogenesis, progressively restoring volume, firmness, and smoothness to treated areas. Unlike traditional fillers, the results appear gradually over weeks, offering subtle enhancement with long-lasting benefits.
About Sinclair
Sinclair Pharma, headquartered in London, UK, is an international leader in the aesthetics industry. Founded in 1971, Sinclair has built a strong portfolio of differentiated, complementary aesthetic technologies designed to meet clinical needs for effective, high-quality, long-duration, and minimally invasive treatments. The company offers a range of products, including well-known brands like Silhouette Soft, Ellansé, Perfectha, and MaiLi, which are utilized for facial rejuvenation and contouring. These products focus on collagen stimulation to deliver natural-looking results with minimal downtime. Sinclair's innovations extend beyond injectables to energy devices such as Cooltech, Elysion, and Préime DermaFacial, further broadening their impact in the aesthetic market. Since being acquired by Huadong Medicine in 2018, Sinclair has expanded its global footprint, particularly in Europe, Brazil, Mexico, and South Korea, with plans to enter new geographic markets and introduce new product lines in the coming years. The company's commitment to quality and innovation is supported by extensive research and development, making it a trusted partner for aesthetic professionals worldwide.